CD8A and glioblastoma: In this study, we non-invasively evaluated early differences in CD8+ cell infiltration and their longitudinal effects associated with combination therapy oHSV and anti-PD1 via [89Zr]-CD8 ImmunoPET imaging in an orthotopic murine glioblastoma model.